Skip to content
10-Q

Quarterly Report

LONGEVITY HEALTH HOLDINGS, INC. XAGE XAGEW

0001193125-25-283127

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 1.78M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.31M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 696.85K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 717.21K sh
Capex Q3 2025 · Sep 30, 2025 $14.22K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.02M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$3.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$3.98M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$3.74M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$4.71M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$4.06M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$1.37M
Stockholders Equity Q3 2025 · Dec 31, 2023 $24.75M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.84M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.88M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.28M
Total Liabilities Q3 2025 · Dec 31, 2024 $6.19M
Current Assets Q3 2025 · Sep 30, 2025 $2.84M
Current Assets Q3 2025 · Dec 31, 2024 $955.55K
Total Assets Q3 2025 · Sep 30, 2025 $3.3M
Total Assets Q3 2025 · Dec 31, 2024 $1.47M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.83
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.68
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$4.13
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$13.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.83
Eps Basic Q3 2025 · Sep 30, 2025 −$3.68
Eps Basic restated Q3 2025 · Sep 30, 2024 −$4.13
Eps Basic restated Q3 2025 · Sep 30, 2024 −$13.19
Rd Expense Q3 2025 · Sep 30, 2025 $227.99K
Rd Expense Q3 2025 · Sep 30, 2025 $684.81K
Rd Expense Q3 2025 · Jun 30, 2025 $259.9K
Rd Expense Q3 2025 · Jun 30, 2025 $456.82K
Rd Expense Q3 2025 · Sep 30, 2024 $331.81K
Rd Expense Q3 2025 · Sep 30, 2024 $865.29K
Net Income Q3 2025 · Sep 30, 2025 −$1.43M
Net Income Q3 2025 · Sep 30, 2025 −$4.82M
Net Income Q3 2025 · Sep 30, 2024 −$2.88M
Net Income Q3 2025 · Sep 30, 2024 −$9.45M
Operating Income Q3 2025 · Sep 30, 2025 −$1.47M
Operating Income Q3 2025 · Sep 30, 2025 −$4.84M
Operating Income Q3 2025 · Sep 30, 2024 −$1.42M
Operating Income Q3 2025 · Sep 30, 2024 −$3.99M
Gross Profit Q3 2025 · Sep 30, 2025 $254.46K
Gross Profit Q3 2025 · Sep 30, 2025 $826.94K
Gross Profit Q3 2025 · Sep 30, 2024 $15.68K
Gross Profit Q3 2025 · Sep 30, 2024 $27.71K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $171.4K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $612.89K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.84K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.13K
Revenue Q3 2025 · Sep 30, 2025 $425.86K
Revenue Q3 2025 · Sep 30, 2025 $1.44M
Revenue Q3 2025 · Sep 30, 2024 $20.52K
Revenue Q3 2025 · Sep 30, 2024 $32.84K
Sga Expense Q3 2025 · Jun 30, 2025 $1.43M
Sga Expense Q3 2025 · Jun 30, 2025 $2.71M